These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 400906

  • 1. Adverse effects of water-soluble contrast media in myelography, cisternography and ventriculography. A review with special reference to metrizamide.
    Skalpe IO.
    Acta Radiol Suppl; 1977; 355():359-70. PubMed ID: 400906
    [Abstract] [Full Text] [Related]

  • 2. Adhesive arachnoiditis following lumbar myelography.
    Skalpe IO.
    Spine (Phila Pa 1976); 1978 Mar; 3(1):61-4. PubMed ID: 205956
    [Abstract] [Full Text] [Related]

  • 3. Ventriculography with water-soluble contrast media.
    Sortland O, Hovind K.
    Acta Radiol Suppl; 1977 Mar; 355():223-36. PubMed ID: 318145
    [Abstract] [Full Text] [Related]

  • 4. [Use of non-ionogenic contrast media for myelography].
    Sviridov NK, Popova ZP, Varfolomeeva VN.
    Zh Vopr Neirokhir Im N N Burdenko; 1984 Mar; (4):50-3. PubMed ID: 6388202
    [No Abstract] [Full Text] [Related]

  • 5. [Contrast density and side effect rate in lumbar myelography--a clinical comparison of Meglumin-Iocarmate and Metrizamide].
    Yücel M.
    Z Orthop Ihre Grenzgeb; 1979 Feb; 117(1):115-8. PubMed ID: 371174
    [Abstract] [Full Text] [Related]

  • 6. Comparison of iothalamate meglumine, metrizamide and iodophendylate in cerebral ventriculography. A clinical, radiological and histopathological study in the rat.
    Klee JG, Praestholm J.
    Invest Radiol; 1975 Feb; 10(3):244-50. PubMed ID: 1079522
    [Abstract] [Full Text] [Related]

  • 7. Effect of blood on arachnoiditis from aqueous myelographic contrast media.
    Haughton VM, Ho KC.
    AJR Am J Roentgenol; 1982 Sep; 139(3):569-70. PubMed ID: 6810668
    [Abstract] [Full Text] [Related]

  • 8. [Side effect of metrizamide and meglumine iocarmate in lumbar myelography. A prospective, parallel, interview study (author's transl)].
    Laasonen EM, Ehrström J, Toivakka E, Roukkula M.
    Rofo; 1977 Nov; 127(5):483-6. PubMed ID: 144686
    [Abstract] [Full Text] [Related]

  • 9. Lumbar myelography with metrizamide-a new non-ionic contrast medium.
    Grainger RG.
    Br J Radiol; 1976 Dec; 49(588):996-1003. PubMed ID: 793673
    [Abstract] [Full Text] [Related]

  • 10. The risk of arachnoiditis from experimental nonionic contrast media.
    Haughton VM, Ho KC.
    Radiology; 1980 Aug; 136(2):395-7. PubMed ID: 6773100
    [Abstract] [Full Text] [Related]

  • 11. Lumbar myelography with meglumine iocarmate and metrizamide.
    Hindmarsh T.
    Acta Radiol Diagn (Stockh); 1975 May; 16(3):209-22. PubMed ID: 1100789
    [Abstract] [Full Text] [Related]

  • 12. Arachnoiditis following myelography with water-soluble agents. The role of contrast medium osmolality.
    Haughton VM, Ho KC, Unger GF.
    Radiology; 1977 Dec; 125(3):731-3. PubMed ID: 412226
    [Abstract] [Full Text] [Related]

  • 13. Metrizamide as contrast medium for myelography and ventriculography. Preliminary clinical experiences.
    Gonsette RE.
    Acta Radiol Suppl; 1973 Dec; 335():346-58. PubMed ID: 4549779
    [No Abstract] [Full Text] [Related]

  • 14. Lumbar leptomeningeal and radicular reactions after the subarachnoid injection of water-soluble contrast media, meglumine iocarmate (dimer-Xr) and metrizamide (amipaquer). An experimental study in the pig.
    Punto L.
    Acta Vet Scand Suppl; 1980 Dec; (73):1-47. PubMed ID: 6930154
    [No Abstract] [Full Text] [Related]

  • 15. Amipaque myelography. The side effects compared with Dimer X.
    Ahlgren P.
    Neuroradiology; 1975 Aug 29; 9(4):197-202. PubMed ID: 1186965
    [Abstract] [Full Text] [Related]

  • 16. Experimental production of arachnoiditis with water-soluble myelographic media.
    Haughton VM, Ho KC, Larson SJ, Unger GF, Correa-Paz F.
    Radiology; 1977 Jun 29; 123(3):681-5. PubMed ID: 404664
    [Abstract] [Full Text] [Related]

  • 17. Advances in ventriculography and myelography with the non-ionic constrast medium metrizamide.
    Gonsette RE.
    Acta Radiol Suppl; 1976 Jun 29; 347():467-76. PubMed ID: 207136
    [Abstract] [Full Text] [Related]

  • 18. Late meningeal effects of myelographic contrast media with special reference to metrizamide.
    Hansen EB, Fahrenkrug A, Praestholm J.
    Br J Radiol; 1978 May 29; 51(605):321-7. PubMed ID: 638401
    [Abstract] [Full Text] [Related]

  • 19. The use of metrizamide for myelography.
    de Villiers PD, Snyman PJ, van Rensburg M.
    S Afr Med J; 1979 Oct 13; 56(16):631-4. PubMed ID: 550419
    [Abstract] [Full Text] [Related]

  • 20. Comparison of arachnoiditis produced by meglumine iocarmate and metrizamide myelography in an animal model.
    Haughton VM, Ho KC, Larson SJ, Unger GF, Correa-Paz F.
    AJR Am J Roentgenol; 1978 Jul 13; 131(1):129-32. PubMed ID: 97964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.